AWARE: Reducing Alcohol Use and Sexual Dysfunction in Survivors of Sexual Trauma

Sponsor
Lifespan (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05599620
Collaborator
(none)
90
1
2
39
2.3

Study Details

Study Description

Brief Summary

The goal of this clinical trial is to develop and evaluate the preliminary efficacy of an intervention to address alcohol use, sexual distress, and sexual assault risk among college women with a history of sexual victimization. The main questions it aims to answer are: 1) what is the feasibility of the recruitment method, research design, interventionist training methods, and delivery of the intervention; 2) does the intervention, relatively to control, the 2- and 6-month follow-up produces reductions in the quantity/frequency of alcohol use and heavy drinking, sexual distress, and sex-related drinking motives, and sexual revictimization. Participants will engage in both individual and group based intervention for alcohol use, sexual distress, and sexual assault risk. Follow-up assessments are completed at 2- and 6-months following program completion. The intervention will be compared to a general health promotion control group.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: AWARE
  • Behavioral: General Health Promotion
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
90 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Reducing Alcohol Use and Sexual Dysfunction in Survivors of Sexual Trauma
Anticipated Study Start Date :
Jan 1, 2023
Anticipated Primary Completion Date :
Apr 1, 2026
Anticipated Study Completion Date :
Apr 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: AWARE Program

The AWARE program addresses alcohol use, sexual distress and sexual revictimization risk.

Behavioral: AWARE
AWARE addresses alcohol use, sexual distress, and sexual assault risk among college women with a history of sexual victimization.

Placebo Comparator: General Health Promotion

The General Health Promotion program is a attention and dose-matched comparison condition.

Behavioral: General Health Promotion
General Health Promotion is an attention and dose matched intervention with no overlapping components with AWARE.

Outcome Measures

Primary Outcome Measures

  1. Alcohol Use [Change from baseline alcohol use at 6 months.]

    The number of past month drinking days (Minmum = 0, Maximum = 30), average drinks per drinking day (Minmum = 0, Maximum = unspecificed), number of heavy drinking days (Minimum = 0, Maximum = 30), assessed via the Time Line Follow Back, with greater scores meaning worse outcomes.

  2. Sexual Distress [Change from overall levels of sexual dysfunction at 6 months.]

    Assessed via the Female Sexual Dysfunction Index, Minumum = 2, Maximum = 36 with higher scores meaning worse outcomes.

  3. Sexual Victimization [Reductions in severity and frequency of victimization in comparison to control at 6 months.]

    Assessed via the Sexual Experiences Survey. Scored based on frequency and severity, Minumum = 0, Maximum = 63, higher scores means worse outcomes.

Secondary Outcome Measures

  1. Sex-Related Drinking Motives [Change in sexual related drinking motives at 6 months.]

    Assessed via 2 subscales of the Drinking Motives Questionnaire, Minimum = 8, Maximum

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 24 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. be between the ages of 18 and 24;

  2. speak and comprehend English;

  3. report a history of attempted or completed penetrative acts of sexual victimization (i.e., oral, vaginal, anal) since age 14 via incapacitation or force;

  4. report exceeding the national recommended limits for daily drinking (4 or more for women) on two or more occasions in the past month;

  5. report past month sexual activity;

  6. exceed the clinical cut point on the Female Sexual Functioning Index.

Exclusion Criteria:
  1. suicide risk on the Beck Depression Inventory;

  2. screen positive on the Alcohol Use Withdrawal Checklist.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Rhode Island Hospital Providence Rhode Island United States 02904

Sponsors and Collaborators

  • Lifespan

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Lindsay Orchowski Ph.D., Associate Professor (Research), Lifespan
ClinicalTrials.gov Identifier:
NCT05599620
Other Study ID Numbers:
  • R34AA028402
First Posted:
Oct 31, 2022
Last Update Posted:
Oct 31, 2022
Last Verified:
Oct 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 31, 2022